IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pilotto, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.249
EU - Europa 1.834
AS - Asia 1.006
OC - Oceania 7
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 8.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.218
CN - Cina 508
UA - Ucraina 372
DE - Germania 298
HK - Hong Kong 288
IT - Italia 286
FR - Francia 273
SG - Singapore 172
IE - Irlanda 154
GB - Regno Unito 147
FI - Finlandia 140
CZ - Repubblica Ceca 50
RU - Federazione Russa 29
PL - Polonia 27
CA - Canada 22
SE - Svezia 15
BE - Belgio 14
VN - Vietnam 10
IN - India 8
MX - Messico 8
ES - Italia 7
AU - Australia 6
NL - Olanda 6
BR - Brasile 5
JP - Giappone 5
AT - Austria 4
EU - Europa 4
IR - Iran 4
RO - Romania 3
ID - Indonesia 2
MU - Mauritius 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 8.109
Salva come PNG Salva come JPEG
Città #
Fairfield 884
Woodbridge 575
Ashburn 449
Houston 383
Seattle 372
Cambridge 327
Jacksonville 314
Wilmington 292
Hong Kong 286
Ann Arbor 261
Princeton 236
Chandler 188
New York 174
Dublin 143
Helsinki 109
Dearborn 96
Singapore 95
Nanjing 94
Beijing 83
San Diego 68
Des Moines 56
Shenyang 48
Brescia 42
Nanchang 36
Brno 33
Changsha 31
Shanghai 31
London 30
Boardman 27
Warsaw 26
Milan 25
Jinan 23
Ningbo 22
Hebei 21
Romola 21
San Francisco 21
Lancaster 19
Los Angeles 19
Tianjin 19
Norwalk 18
Lappeenranta 17
Olomouc 17
Toronto 15
Brussels 14
Verona 13
Hangzhou 12
Jiaxing 12
Kilburn 12
Kunming 12
Zhengzhou 12
Munich 11
Dong Ket 10
Guangzhou 8
Washington 8
Brindisi 6
Darfo 6
Florence 6
Hefei 6
Orange 6
San Mateo 6
Taizhou 6
Wipperfürth 6
Fuzhou 5
Hounslow 5
Murcia 5
Augusta 4
Bielefeld 4
Bologna 4
Cascina 4
Ciudad Nezahualcoyotl 4
Cologno Monzese 4
Frankfurt am Main 4
Lanzhou 4
Melbourne 4
Nürnberg 4
Rende 4
Rome 4
Salina Cruz 4
Wandsworth 4
Ardabil 3
Chiswick 3
Falkenstein 3
Falls Church 3
Haikou 3
Pavia 3
Portland 3
Prescot 3
Pune 3
Redwood City 3
Rovato 3
Taiyuan 3
Tokyo 3
Vienna 3
Ancona 2
Bangkok 2
Bedizzole 2
Belgrade 2
Bienno 2
Busto Arsizio 2
Calcio 2
Totale 6.345
Salva come PNG Salva come JPEG
Nome #
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 155
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 153
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 152
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 142
COVID-19 impact on consecutive neurological patients admitted to the emergency department 141
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 138
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 123
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 122
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 122
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 116
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 116
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 114
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 113
Vascular risk factors and cognition in Parkinson's disease 113
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 111
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 110
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 110
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 108
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 108
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 107
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 107
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 106
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 103
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 103
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 102
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 102
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 101
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 100
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 99
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 97
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 97
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 96
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 96
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 96
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 95
Disease-modifying therapies in frontotemporal lobar degeneration. 94
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 94
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 93
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 93
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 92
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 91
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 91
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 91
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 90
Central serous chorioretinopathy: Pathogenesis and management 88
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 85
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 83
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 83
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 83
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 83
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 82
Metabolic patterns across core features in dementia with lewy bodies 81
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 79
null 77
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 77
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 73
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 72
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 68
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 63
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 61
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 60
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 59
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 49
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 48
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 46
Design and test of an autonomous reconfigurable dynamic investigation test-rig on haptics (ARDITA) for pre-screening of the peripheral neuropathy diseases 46
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 44
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 44
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 43
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 41
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 39
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 38
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies 37
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 36
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 36
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 36
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 36
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 36
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 35
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 35
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential 34
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 34
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 33
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies 33
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 33
Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies 33
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 32
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: Results of NMR metabolomics investigation 31
Long-term unsupervised mobility assessment in movement disorders 31
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies 31
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile 30
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 30
Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - The ComOn-study 29
Gender-Related Vulnerability of Dopaminergic Neural Networks in Parkinson's Disease 29
Response to Abboud 29
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 28
Validation of the Italian version of the PSP Quality of Life questionnaire 28
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 28
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 28
The effect of age and gender on anti-saccade performance: Results from a large cohort of healthy aging individuals 27
Totale 7.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.613 0 0 119 204 134 228 213 211 152 218 48 86
2020/20211.874 17 263 106 171 180 261 117 148 162 200 152 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/2025126 56 26 44 0 0 0 0 0 0 0 0 0
Totale 8.352